Facebook Pixel 3 trends to drive and shape the future of digital health | BioSpectrum Asia - Business - Lee esta historia en Magzter.com
Vuélvete ilimitado con Magzter GOLD

Vuélvete ilimitado con Magzter GOLD

Obtenga acceso ilimitado a más de 9000 revistas, periódicos e historias Premium por solo

$149.99
 
$74.99/Año

Intentar ORO - Gratis

3 trends to drive and shape the future of digital health

BioSpectrum Asia

|

BioSpectrum Asia July 2021

A year on, the effects of the COVID-19 pandemic on the world continue to be profound. More than 90 per cent of global executives polled by McKinsey and Company believe COVID-19 will fundamentally change their businesses, and 85 per cent predict lasting changes in customers’ preferences. Being on the frontlines of the fight against COVID-19 has placed unparalleled demands on the healthcare industry no less – and quite possibly more – than any other sector.

3 trends to drive and shape the future of digital health

Chintan Desai, ASEAN CEO, GE Healthcare, Singapore

Healthcare systems across the world were initially caught off-guard when tasked with this unprecedented crisis, which required the urgent mobilisation of resources and affected the whole population.

Unfortunately, the fight is still far from over. In recent weeks, new, more contagious variants of the virus have emerged in countries such as India, the United Kingdom, and South Africa. These intractable variants have spread rapidly across the region sending countries into another round of lockdowns, outpacing the global vaccination programme determined to be the best weapon in fighting the pandemic.

Global social distancing, infection control, and lockdown measures have created a plethora of challenges for the healthcare industry as it looks to tackle the influx of patients while continuing to deliver ongoing care that remains critical. However, for an industry that thrives through constant discovery, the eventual speed and scale of its response to COVID-19 has been nothing short of remarkable.

The pandemic has proved to be a powerful catalyst in bringing forward the industry’s digitalisation. We are now seeing the convergence of digital technologies with healthcare, to make medicine more personalised and precise.

As the situation evolves, it is important we continue to invest in building new capabilities today so that we have the capacity to deal with the emergencies of tomorrow. Here are three trends I believe will permanently drive and shape the way healthcare is delivered and received, for the future of digital health.

1. Accelerating precision health by leveraging digital technology

MÁS HISTORIAS DE BioSpectrum Asia

BioSpectrum Asia

BioSpectrum Asia

India Health Fund supports D-Nome to bolster molecular TB screening in India

India Health Fund (IHF), a Tata Trusts initiative, is poised to transform tuberculosis (TB) screening at scale by enabling the development of the world's most affordable molecular screening tool for TB.

time to read

1 min

BioSpectrum Asia May 2026

BioSpectrum Asia

BioSpectrum Asia

BioOra and Octane Biotech sign LoI to expand cell therapy manufacturing using Cocoon Platform

BioOra, a commercialstage cell therapy company advancing CAR-T therapies for cancer patients, & Canadabased Octane Biotech Inc., an Octane Medical Group Company, has announced the signing of a Letter of Intent (LOI) to collaborate on the co-development & deployment of advanced cell therapies using the Cocoon automated cell therapy manufacturing platform.

time to read

1 min

BioSpectrum Asia May 2026

BioSpectrum Asia

BioSpectrum Asia

NTU and NHG Health partner to advance healthcare education in Singapore

NHG Health's inaugural E3 (Educate, Elevate, Evolve) conference, held recently, was marked by a new partnership with Nanyang Technological University (NTU) Singapore, signalling a significant step in advancing healthcare education through interdisciplinary collaboration.

time to read

1 min

BioSpectrum Asia May 2026

BioSpectrum Asia

Gene Solutions introduces non-invasive prenatal screening technology triSure in Taiwan

Singapore-based startup Gene Solutions has introduced triSure, a revolutionary non-invasive prenatal screening technology.

time to read

1 min

BioSpectrum Asia May 2026

BioSpectrum Asia

How FemTech Spurt in APAC is Redefining Healthcare

Despite representing half the global population, women's health has historically received only a fraction of healthcare innovation and investment.

time to read

4 mins

BioSpectrum Asia May 2026

BioSpectrum Asia

China's Colossal Ageing Population and Low Birth Rate Challenge

China's recent policy initiatives pertaining to long-term care insurance, maternity insurance expansion, and primary healthcare reform reflect a coordinated attempt to address deep structural demographic challenges—most notably 'rapid population ageing' and declining birth rates.

time to read

2 mins

BioSpectrum Asia May 2026

BioSpectrum Asia

"We need to prioritise research as several common AYA cancers are significantly under-studied in Asian populations"

At the SingHealth Presidents' Scientific and Partners in Social-care (SPSOC) Conference, Assistant Professor Eileen Poon, Senior Consultant in Medical Oncology at the National Cancer Centre Singapore (NCCS) delivered an enlightening presentation.

time to read

7 mins

BioSpectrum Asia May 2026

BioSpectrum Asia

Shimadzu Scientific Instruments opens laboratory in San Francisco Bay Area

Shimadzu Scientific Instruments (SSI) has opened its new research and development (R&D) facility in South San Francisco, California, US.

time to read

1 min

BioSpectrum Asia May 2026

BioSpectrum Asia

"Building a lean team with deep operational expertise increases likelihood of success in rare disease drug development"

More than 300 million people worldwide are impacted by over 10,000 rare diseases, i.e. more than cancer and AIDS combined.

time to read

5 mins

BioSpectrum Asia May 2026

BioSpectrum Asia

BioSpectrum Asia

Qiagen expands into bloodstream infection syndromic testing with new rapid QIAstat-Dx panel

Qiagen N.V. has announced its expansion into syndromic testing for bloodstream infections with the launch of the CE-IVDR-certified QIAstat-Dx BCID GPF Plus AMR Panel.

time to read

1 min

BioSpectrum Asia May 2026

Translate

Share

-
+

Change font size